Zydus Lifesciences Ltd Nine Monthly Results

Gross Sales

16,283.6

13,655.1

12,025.3

11,148.8

10,616.8

Excise Duty

0

0

0

0

0

Net Sales

16,283.6

13,655.1

12,025.3

11,148.8

10,616.8

Other Operating Income

430

358.5

544.4

316.4

189.7

Other Income

188.9

147.5

148.8

2,664.2

153.5

Total Income

16,902.5

14,161.1

12,718.5

14,129.4

10,960

Total Expenditure

11,780.6

10,274

9,970.7

9,014.6

8,567.7

PBIDT

5,121.9

3,887.1

2,747.8

5,114.8

2,392.3

Interest

89.3

46.6

102.2

88.5

140

PBDT

5,032.6

3,840.5

2,645.6

5,026.3

2,252.3

Depreciation

677.9

558.8

544.1

550.7

523.6

Minority Interest Before NP

0

0

0

0

0

Tax

1,058.7

1,027.7

460.6

323.8

338.1

Deferred Tax

-70

-371.4

-10

28.4

-15.4

Reported Profit After Tax

3,366

2,625.4

1,650.9

4,123.4

1,406

Minority Interest After NP

74.3

49.5

70

75.1

-5

Net Profit after Minority Interest

3,354.6

2,677.2

1,663.7

4,089.9

1,454.6

Extra-ordinary Items

0

1.13

-4.67

2,405.58

-104.99

Adjusted Profit After Extra-ordinary item

3,354.6

2,676.07

1,668.37

1,684.32

1,559.59

EPS (Unit Curr.)

33.34

26.45

16.33

39.95

14.21

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

100.6

101.2

101.2

102.4

102.4

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

31.45

28.46

22.85

45.87

22.53

PBDTM(%)

30.9

28.12

22

45.08

21.21

PATM(%)

20.67

19.22

13.72

36.98

13.24